Treatment group:Dupilumab
Sponsors
Children's Hospital of Chongqing Medical University
Conditions
Atopic Dermatitis (AD)
Phase 4
A single-center clinical cohort study of dupilumab in the treatment of moderate-to-severe atopic dermatitis aged 6 years and older
RecruitingChiCTR2100053167
Start: 2021-12-15Updated: 2022-09-20
Real-world efficacy and safety of dupilumab in chinese children aged 6 months to 5 years with severe atopic dermatitis: a single-centre, prospective, open-label study
Active, not recruitingChiCTR2200063385
Start: 2022-09-05Updated: 2023-04-17